Tabernero Caturla, J., Zaanan, A., Doi, T., Lorenzen, S., Van Cutsem, E., Alsina Maqueda, M., & Shitara, K. (2021). Trifluridine/tipiracil versus placebo for third or later lines of treatment in metastatic gastric cancer: An exploratory subgroup analysis from the TAGS study.
Citación estilo ChicagoTabernero Caturla, Josep, Aziz Zaanan, Toshihiko Doi, S. Lorenzen, Eric Van Cutsem, Maria Alsina Maqueda, y Kohei Shitara. Trifluridine/tipiracil Versus Placebo for Third or Later Lines of Treatment in Metastatic Gastric Cancer: An Exploratory Subgroup Analysis From the TAGS Study. 2021.
Cita MLATabernero Caturla, Josep, et al. Trifluridine/tipiracil Versus Placebo for Third or Later Lines of Treatment in Metastatic Gastric Cancer: An Exploratory Subgroup Analysis From the TAGS Study. 2021.